2 more cancer drugs in shortage

Two more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.

These drugs are the latest in a growing list of oncology medications in short supply:

Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug. 

Iobenguane I-131 injections: Progenics Pharmaceuticals stopped making two solutions because of low demand for the oncology medication.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars